Apolipoprotein E (APOE) e4 allele on chromosome 19, identified using Sanger and family-based approaches, significantly contributes to AD diagnosis in homozygous (APOE e4/e4) and heterozygous (APOE e3/e4) conditions. This evidence concerns the gene APOE and Alzheimer disease.